GlassScriptPhysician profile
Boris Chernobilsky
NPI 1609821297
$6,423.35
in general payments reported to CMS, 2019-2025
17 companies · $656 in 2025
The $656 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,124 · 2020: $1,144 · 2021: $452 · 2022: $1,020 · 2023: $772 · 2024: $1,255 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,503 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,503.36 |
| Education | $180.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,470.38 | 2019-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,276.58 | 2019-2024 | |
| Optinose US, INC. | $1,213.96 | 2019-2023 | |
| Avadel Cns Pharmaceuticals, LLC | $287.42 | 2025 | Lumryz |
| Axsome Therapeutics, INC. | $256.63 | 2023-2025 | Sunosi |
| Harmony Biosciences LLC | $168.81 | 2020-2022 | |
| Lucid Diagnostics INC. | $153.38 | 2021 | |
| Livanova USA, INC. | $152.91 | 2025 | Thn Sleep Therapy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.15 | 2020 | |
| Genzyme Corporation | $94.45 | 2021-2023 | |
| Neurent Medical Limited | $61.68 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Medtronic, INC. | $38.70 | 2025 | |
| Aerin Medical INC. | $36.46 | 2022 | |
| Itamar Medical INC | $33.96 | 2022 | |
| Ambu INC. | $33.69 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $32.24 | 2021-2023 | Nucala |
| Intersect Ent, INC. | $15.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Chernobilsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.